Executives On The Move: New CEOs For Lengo, Draupnir And OncoSec
Leadership moves are also reported at CureVac, while Esperion Therapeutics and Palatin Technologies get new chief medical officers.
You may also be interested in...
Scrip and Pink Sheet editors join Datamonitor Healthcare analysts to discuss Biogen's Aduhelm for Alzheimer's disease, including the expected launch trajectory, early commercial barriers to uptake and the Medicare reimbursement environment.
Regeneron's antibody cocktail gets emergency authorization for post-exposure prophylaxis from the US FDA. Daewoong's camostat shows efficacy in older patients in South Korean trial.
New chief medical officer at SpringWorks Therapeutics, while Biomea Fusion gets new chief financial officer.